| 101 |
16996216 | Down-regulation of ABCB1 transporter by atorvastatin in a human hepatoma cell line and in human peripheral blood mononuclear cells. | 2006 Dec |
1 |
| 102 |
15331656 | Intrinsic and acquired forms of resistance against the anticancer ruthenium compound KP1019 [indazolium trans-[tetrachlorobis(1H-indazole)ruthenate (III)] (FFC14A). | 2005 Jan |
1 |
| 103 |
15796199 | In vitro search for synergy between flavonoids and epirubicin on multidrug-resistant cancer cells. | 2005 Mar-Apr |
2 |
| 104 |
15963852 | RNAi-mediated knockdown of P-glycoprotein using a transposon-based vector system durably restores imatinib sensitivity in imatinib-resistant CML cell lines. | 2005 Jul |
1 |
| 105 |
16229491 | Interaction of LDS-751 and rhodamine 123 with P-glycoprotein: evidence for simultaneous binding of both drugs. | 2005 Oct 25 |
1 |
| 106 |
15022031 | P-glycoprotein function in the elderly. | 2004 Apr |
1 |
| 107 |
15040543 | Intracellular accumulation of nelfinavir and its relationship to P-glycoprotein expression and function in HIV-infected patients. | 2004 Feb |
1 |
| 108 |
15138133 | Detection of multidrug resistant gene 1 in pancreatic cancer. | 2004 May |
2 |
| 109 |
15161039 | New silicon compounds as resistance modifiers against multidrug-resistant cancer cells. | 2004 Mar-Apr |
2 |
| 110 |
15201669 | P-glycoprotein activity is decreased in CD4+ but not CD8+ lung allograft-infiltrating T cells during acute cellular rejection. | 2004 Jun 15 |
1 |
| 111 |
15254709 | Overexpression of cyclooxygenase-2 in childhood ependymomas: role of COX-2 inhibitor in growth and multi-drug resistance in vitro. | 2004 Aug |
1 |
| 112 |
15301426 | Screening novel, potent multidrug-resistant modulators from imidazole derivatives. | 2004 |
1 |
| 113 |
15351776 | Inhibitory effect of a bitter melon extract on the P-glycoprotein activity in intestinal Caco-2 cells. | 2004 Oct |
2 |
| 114 |
15547738 | P-glycoprotein 170 expression and function as an adverse independent prognostic factor in childhood acute lymphoblastic leukemia. | 2004 Dec |
2 |
| 115 |
12542697 | New insights into the P-glycoprotein-mediated effluxes of rhodamines. | 2003 Feb |
4 |
| 116 |
12682648 | Age-related changes of P-glycoprotein-mediated rhodamine 123 efflux in normal human bone marrow hematopoietic stem cells. | 2003 Apr |
1 |
| 117 |
12975485 | Interaction of imatinib mesilate with human P-glycoprotein. | 2003 Nov |
2 |
| 118 |
14522974 | Methanethiosulfonate derivatives of rhodamine and verapamil activate human P-glycoprotein at different sites. | 2003 Dec 12 |
1 |
| 119 |
14567628 | Evaluation of an immortalized retinal endothelial cell line as an in vitro model for drug transport studies across the blood-retinal barrier. | 2003 Sep |
1 |
| 120 |
14666249 | Age-related changes of the multidrug resistance P-glycoprotein function in normal human peripheral blood T lymphocytes. | 2003 Dec |
1 |
| 121 |
11801536 | The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. | 2002 Jan |
2 |
| 122 |
11849198 | St Johns wort increases expression of P-glycoprotein: implications for drug interactions. | 2002 Jan |
2 |
| 123 |
11945073 | Enhancement of transgene expression by combining glucocorticoids and anti-mitotic agents during transient transfection using DNA-cationic liposomes. | 2002 Apr |
1 |
| 124 |
11994059 | MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine. | 2002 May |
1 |
| 125 |
12091325 | P-glycoprotein targeting: a unique strategy to selectively eliminate immunoreactive T cells. | 2002 Jul 15 |
1 |
| 126 |
12126537 | [Transfection of MDR1-mRNA into human mononuclear cells to improve their resistance to anticancer agents, an in vitro study]. | 2002 Jun 25 |
2 |
| 127 |
12195825 | Effect of hr-IL2 treatment on intestinal P-glycoprotein expression and activity in Caco-2 cells. | 2002 Aug |
1 |
| 128 |
12373300 | Dehydrothyrsiferol does not modulate multidrug resistance-associated protein 1 resistance: a functional screening system for MRP1 substrates. | 2002 Nov |
1 |
| 129 |
12432340 | P-glycoprotein expression in human retinal pigment epithelium. | 2002 Nov 11 |
2 |
| 130 |
11237063 | MDR1 expression in poor-risk acute myeloid leukemia with partial or complete monosomy 7. | 2001 Mar |
1 |
| 131 |
11434506 | The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells. | 2001 Jun |
3 |
| 132 |
11587212 | Activity and expression of the multidrug resistance proteins P-glycoprotein, MRP1, MRP2, MRP3 and MRP5 in de novo and relapsed acute myeloid leukemia. | 2001 Oct |
1 |
| 133 |
11104578 | Antitumour activity of novel taxanes that act at the same time as cytotoxic agents and P-glycoprotein inhibitors. | 2000 Dec |
1 |
| 134 |
11129093 | Lymphocyte P-glycoprotein expression and activity before and after rifampicin in man. | 2000 Sep-Oct |
1 |
| 135 |
11218898 | [Study of mdr1 antisense oligodeoxynucleotides on reversal of multidrug resistance in ovarian carcinoma cell line SKOV3]. | 2000 Nov |
5 |
| 136 |
11778227 | [Reversion of multidrug resistance in vitro of lung adenocarcinoma by mdr1 ribozyme]. | 2000 May |
1 |
| 137 |
9864175 | Efflux of rhodamine from CD56+ cells as a surrogate marker for reversal of P-glycoprotein-mediated drug efflux by PSC 833. | 1999 Jan 1 |
2 |
| 138 |
9891078 | Studies of human MDR1-MDR2 chimeras demonstrate the functional exchangeability of a major transmembrane segment of the multidrug transporter and phosphatidylcholine flippase. | 1999 Feb |
4 |
| 139 |
9920827 | Treatment of refractory and relapsed acute myelogenous leukemia with combination chemotherapy plus the multidrug resistance modulator PSC 833 (Valspodar). | 1999 Feb 1 |
2 |
| 140 |
10195430 | Cmdr1, a chicken P-glycoprotein, confers multidrug resistance and interacts with estradiol. | 1999 Feb |
1 |
| 141 |
10361105 | Altered multidrug resistance phenotype caused by anthracycline analogues and cytosine arabinoside in myeloid leukemia. | 1999 Jun 15 |
1 |
| 142 |
10379790 | Intrinsic drug resistance in primary and metastatic renal cell carcinoma. | 1999 Jul |
1 |
| 143 |
10585262 | Role of P-glycoprotein in human natural killer-like cell line-mediated cytotoxicity. | 1999 Dec 15 |
1 |
| 144 |
9687882 | The multidrug resistance in human leukemias. Minireview. | 1998 |
1 |
| 145 |
9038218 | Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins. | 1997 Feb 28 |
1 |
| 146 |
9108417 | CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance. | 1997 Apr 15 |
1 |
| 147 |
9205006 | Assays for the analysis of P-glycoprotein in acute myeloid leukemia and CD34 subsets of AML blasts. | 1997 Jul |
1 |
| 148 |
9310367 | Efficiency of P-glycoprotein-mediated exclusion of rhodamine dyes from multidrug-resistant cells is determined by their passive transmembrane movement rate. | 1997 Aug 15 |
3 |
| 149 |
9311609 | Development and characterisation of novel human multidrug resistant mammary carcinoma lines in vitro and in vivo. | 1997 Sep 4 |
1 |
| 150 |
9322679 | Expression and functional activity of P-glycoprotein in adult acute myelogenous leukemia patients. | 1997 Jul-Aug |
1 |